Related Funds
| Fund Name | Location |
| AES Corporation | Massachusetts, Peabody, United States |
| Aschendorff NEXT | Germany, Münster, Nordrhein-Westfalen |
| Bail Capital | - |
| Credence Family Office | Bengaluru, India, Karnataka |
| FINUP | Beijing, Beijing, China |
| Global Blue | Eysins, Geneve, Switzerland |
| Glynn Capital Management | California, Menlo Park, United States |
| Haitong International Securities Group | China, Shanghai |
| Lurssen | Bremen, Free Hanseatic City of Bremen, Germany |
| Milamber Ventures | England, London, United Kingdom |
| MOVIDA JAPAN | Japan, Tokyo |
| Random House Ventures | New York, New York, United States |
| Related Fund Management | New York, New York, United States |
| RooGreen Ventures LLP | England, Manchester, United Kingdom |
| Sherpa | Australia, New South Wales, The Rocks |
| SOURCENEXT | Chiyoda, Japan |
| Spark Digital Capital | New York, New York, United States |
| Teall Investments | North Carolina, United States, Winston Salem |
| TFK CAPITAL PARTNERS | Bukit Merah, Central, Singapore |
| XN | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Labiotech.eu | 18 Sep 2017 | Berlin |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Labiotech.eu | 18 Sep 2017 | Berlin |
